Tokyo, June 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057838) titled 'Overdose safety test' on May 29
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponser:
Institute - Clinical Creative Co., Ltd.
Condition:
Condition - healthy person
Classification by malignancy - Others
Genomic information - NO
Objective:
Intervention:
Interventions/Control_1 - Duration: 4 weeks
Test food: Tea extract
Dosage and administration: 5 tablets of tea extract 100 mg/1 tablet at breakfast, lunch and dinner (15 tablets/day, tea extract 1500 mg/day)
Eligibility:
Age-lower limit - 20...